Day 2 Ai, Data, Analytics & Insights Track (continued)
12:00PM Scaling AI Within Global Corporate Enterprise For Better Decision Making
Arvind Balasundaram Executive Director, Commercial Insights & Analytics, Regeneron Pharmaceuticals, Inc.
Watch the Full Interview »
• Impact Assessment: Identifying and measuring the specific decisions influ- enced by AI within the organization. • Human-AI Collaboration: Determining the optimal balance between AI aug- mentation and human judgment in deci- sion-making processes. • The urgency of staying ahead: Emphasiz- ing the long-term consequences of falling behind in the adoption of emerging tech- nologies. Attendees will gain practical guidance on scaling AI initiatives, maximizing their im- pact on business outcomes, and fostering a data-driven culture.
Arvind Balasundaram, Executive Director, Commercial Insights & Analytics, Regeneron Pharmaceuticals, Inc. This session tackles the critical challenge of scaling AI within global corporations to en- hance decision-making. Moving beyond isolated pilot projects, it explores: • Overcoming “Pilotitis”: Strategies for transitioning from proof-of-concept to en- terprise-wide AI deployment. • Adapting to the Evolving AI Landscape: Staying ahead of the curve as AI technol- ogies and implementation best practices rapidly change. • Maturing AI Initiatives: Progressing from early-stage exploration to real-world test- ing, validation, and scaling.
12:30PM Partner Session
We’re leaving a bit of breathing room in the agenda to ensure that late-breaking sessions can be placed. Please contact elizabeth.hink- is@informa.com or check back for session details.
Firstname Lastname Title, Company
46 • FEI25
Powered by FlippingBook